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To the Edito
We read w
[1] which
JOURNAL OF HEPATOLOGY
Open access unReply to: ‘‘New imaging assisted methods for liver
ﬁbrosis quantiﬁcation: Is it really favorable to classical
transient elastography?’’in speciﬁc aetiologies of chronic liver diseases. However, there is
mounting evidence that SSI should be considered as an accurate
and promising elastography technique in the ﬁeld of chronic liver
diseases.
To conclude, we are living in an era of great and frequent tech-
nological innovations, which is particularly exciting, but we have
the duty to analyse, criticize and ﬁnally validate as quick as pos-
sible each new progress in order to ultimately provide the best
diagnosis and treatment for all patients.
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To the Editor:
We read with great interest comments by Dr. Lanthier et al. [1]
regarding our article published in Journal of Hepatology [2]. We
thank the authors for their kind interest in our work and
welcome the opportunity to clarify points they raised.
First, in our studywe did not apply nor evenmention reliability
criteria regarding the Supersonic Shear Imaging (SSI) technique. As
Dr. Lanthier said, SSI is quite a recent technique, and to date, no
study has focused on the description or deﬁnition of reliability cri-
teria for this technique. In our study, interquartile range (IQR)/liver
stiffness measurement (LSM) was <0.10 in 207 patients (69%),
between 0.10 and 0.30 in 91 (30%), and >0.30 in 3 patients (1%).
So, it is quite obvious that the reliability criteria of FibroScan
are probably not applicable to SSI, but we believe that the deﬁni-
tion of such criteria requires a large multicentre study and should
not be performed too hastily in a single centre study.
Second, we’d like to clarify the key point that the failure rate of
FibroScan in our study is low, around 2.6%, because the XL probe
was used for obese patients (i.e. with body mass index P30 kg/
m2) (30% of patients of our study). In our experience, the failure
rate of SSI is very close to that of the M probe of FibroScan.
Indeed, we can notice that the failure rate of SSI in our study
(10.4% in the whole population; 28% for obese patients but only
2.6% for others) is close to the failure rate of theM probe described
in the study by de Lédinghen et al. [3] among a patient population
quite representative of our study population although with a
slightly lower BMI (8.4% in the whole population; 26% for obese
patients but only 2.5% for others). Unfortunately, as for ARFI and
FibroScan, the reliability of liver stiffness measurement with
SSI is dependant on the quality of the shear wave transmission,
which rapidly decreases as weight increases. This is likely to be
evident in SSI and ARFI techniques where operators can notice
the strong relationship between the reliability of the LSM and
the quality of the spatial resolution on the B-mode US image.
Finally, as we’ve discussed, we agree that further studies are
needed assessing the diagnostic performances and limits of SSImin infusion in cirrhotic patients with infections other than
spontaneous bacterial peritonitis: End of the story?
r:
ith interest the recent manuscript by Thevenot et al.
adds data to the debate on the potential beneﬁcial
effect of albumin administration during episodes of infections
other than spontaneous bacterial peritonitis (SBP) in cirrhotic
patients [2–4].
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